3. Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019; 69(5):363–85.
https://doi.org/10.3322/caac.21565.
Article
4. Wattacheril J, Kramer JR, Richardson P, Havemann BD, Green LK, Le A, et al. Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther. 2008; 28(9):1166–74.
https://doi.org/10.1111/j.1365-2036.2008.03826.x.
Article
12. Sapkota Y, Mackey JR, Lai R, Franco-Villalobos C, Lupichuk S, Robson PJ, et al. Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility. PLoS One. 2013; 8(6):e64896.
https://doi.org/10.1371/journal.pone.0064896.
Article
14. Goodman J, Weare J. Ensemble samplers with affine invariance. Commun Appl Math Comput Sci. 2010; 5(1):65–80.
Article
20. Joyner C, McMahan C, Baurley J, Pardamean B. A two-phase Bayesian methodology for the analysis of binary phenotypes in genome-wide association studies. Biom J. 2020; 62(1):191–201.
https://doi.org/10.1002/bimj.201900050.
Article
27. Li J, Zeng Z, Chen J, Liu X, Jiang X, Sun W, et al. Pathologic evolution-related Gene Analysis based on both single-cell and bulk transcriptomics in colorectal cancer. J Cancer. 2020; 11(23):6861–73.
https://doi.org/10.7150/jca.49262.
Article
28. Qi L, Ye C, Zhang D, Bai R, Zheng S, Hu W, et al. The effects of differentially-expressed homeobox family genes on the prognosis and HOXC6 on immune microenvironment orchestration in colorectal cancer. Front Immunol. 2021; 12:781221.
https://doi.org/10.3389/fimmu.2021.781221.
Article
30. Pandey A, Davis NA, White BC, Pajewski NM, Savitz J, Drevets WC, et al. Epistasis network centrality analysis yields pathway replication across two GWAS cohorts for bipolar disorder. Transl Psychiatry. 2012; 2(8):e154.
https://doi.org/10.1038/tp.2012.80.
Article